The Lancet6d
A step towards more physiological glucocorticoid dosing in congenital adrenal hyperplasia
On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with ...
American College of Cardiology22d
Adult Congenital and Pediatric Cardiology Member Section
In addition, we collaborate with other sections within ACC as well as other societies to better each other's expertise in improving care for patients with congenital heart disease (CHD). In line with ...
Medscape27d
Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency.
Since 1986, prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-OHD) have been carried out in 239 pregnancies. In 145, diagnoses were made by ...